20th August 2019
An affordable turnkey hysteroscopy simulator
The Bozzini™ Hysteroscopy Simulator by Inovus Medical is a first of its kind in the delivery of close to life, affordable, turnkey hysteroscopy simulation.
The simulator offers an anatomically correct uterus with interchangeable pathologies for practising diagnosis and intraoperative management. Pathologies include endometrial polyps, intrauterine adhesions and endometrial cancer/fibroid as well as a bicornate uterus.
The pathologies offer real-life tissue handling and are a low-cost way of delivering repeated practice of these core hysteroscopic skills. The uterus can be positioned in an anteverted and retroverted orientation allowing trainees to experience the different approach needed for each.
The launch of the Bozzini™ was supported by EIT Health through the € 50 000 HeadStart award. The HeadStart funding, awarded in June, came at the perfect time in the development of the product, enabling Inovus to expedite the final R&D stages and test-bed activity. Having now tested the product with major simulation centres across the UK, the remainder of the HeadStart funding will be utilised in the launch and marketing of the new device.
The Bozzini™ was featured at the EIT Health Zone at the NHS Expo in Manchester on 5-6 September 2018, where visitors had a chance to go through a full simulation.
The Innovation Agency of the North West Coast, a core partner of EIT Health and one of the 14 Academic Health and Science Networks (AHSNs), the innovation arm of the NHS, go through a full simulation at the NHS Expo in this interview.
The simulator allows practice of camera holding and navigation, instrument handling, tissue handling, recognition and diagnosis of pathologies and management of pathologies. The interchangeable consumable pathologies are low cost and easy to change in and out of the simulator making it highly practical as well as cost effective for repeated training and education activities.
Read more about the UK-based winners of the 2018 EIT Health HeadStart award here.
EIT Health helps Tubulis secure €10.7M in funding
Investor Network aids firm doing antibody work
EIT Health-backed start-ups garner big investments
A million each for iLoF and Restorative Neurotechnologies
EIT Health aids 11 start-ups disrupted by COVID-19
Start-up Rescue Instrument gives €5.5M in co-investment